2024 Cancer Immunotherapy Winter School

The 2024 Cancer Immunotherapy Winter School is supported, in part, through independent medical education grants from Genmab US, Inc. and Wilson Wolf. 

Winter School 2024 applications are closed, but you can sign up below to get an update when applications open for Winter School 2025.

Registration & Venue Details

If you can't make it to Austin, you can still register for virtual access. The housing link has closed. Please call the hotel directly to book your room.

The Cancer Immunotherapy Winter School is tailored to early career scientists and clinicians that are new to the field. The curriculum covers the fundamentals of cancer immunotherapy and features separate tracks, including clinical and research, allowing participants to tailor their experiences by selecting the educational path most relevant to their learning goals. 

With separate tracks, including clinical and research, participants can tailor their experience by selecting the educational path most relevant to their learning goals.

Register TODAYBook Your Housing

Registration Rates

Early Registration Regular Registration Onsite Registration
Student Member $100 $350 $400 
Student Non-Member $380  $630  $680
General Member $815  $1,065  $1,115
General Non-Member $920  $1,070  $1,220 
Industry Member $1,705  $1,955  $2,005 
Industry Non-Member $1,870  $2,120  $2,170 

Important Dates

Early Registration Deadline
Wednesday, December 20, 2023 (11:59 p.m. PST) 

Regular Registration Rates End
Wednesday, January 17, 2024 (11:59 p.m. PST) 

Onsite Registration Closes
Friday, February 2, 2024 (11:59 p.m. PST)

Housing & Venue Information

The University of Texas at Austin
AT&T Hotel and Conference Center
1900 University Avenue
Austin, TX 78705

The housing link has closed. Please call the hotel directly to book your room.

Vaccination & Mask Requirements

At SITC programs, our goal is to have a safe and meaningful in-person experience. SITC will refer to the CDC COVID-19 Community Levels to guide health precautions for in-person meetings. In addition, SITC strongly recommends that in-person meeting attendees take the following precautions:

  • Stay up to date with COVID-19 vaccinations
  • Take a rapid COVID test prior to attending a meeting and do not attend in person if you test positive
  • Do not attend the meeting if you have symptoms that could be consistent with a “cold” or any other respiratory infection and leave the meeting if you develop such symptoms
  • Wear a mask in crowded indoor settings
  • Follow all health and safety protocols as required by SITC and local and state health departments
  • Review current CDC and applicable local guidance for protecting yourself from COVID-19.

Attendees will have access to the meeting content online if they are unable to attend in person due to illness or a positive COVID test. For hybrid programs, attendees can change from in-person to online-only registration by contacting events@sitcancer.org.

Registered attendees will be notified in advance of any changes to precautions, recommendations or requirements for a SITC meeting.

Cancellation Policy

Refund requests should be submitted in writing to the SITC office at events@sitcancer.org by January 17, 2024. A $25 processing fee will be charged for all paid registrations. All refunds will be processed within two weeks of receipt. No refunds will be granted if cancellation is received after January 17, 2024.

Travel Awards Available - Applications are closed

Applications are closed  |  Eligibility & Criteria  |  2024 Winners

To support young investigators and clinicians interested in attending the Cancer Immunotherapy Winter School, SITC is pleased to offer applications for travel awards. The Cancer Immunotherapy Winter School Travel Awards are intended for individuals who will attend the program in person. The award amount, up to $1,000, will be reimbursed for eligible expenses associated with travel to attend the 2024 Cancer Immunotherapy Winter School program in person and/or registration for the Cancer Immunotherapy Winter School program.

Two of the five travel awards are reserved for individuals from underrepresented racial and ethnic groups in the biomedical sciences field according to the NIH definition. The information collected in response to the self-identifying process will only be viewed by SITC staff and Cancer Immunotherapy Winter School program organizers.

SITC established the Forward Fund in 2012, to stimulate the development and application of cancer immunology and immunotherapy by financially supporting its education and research. Contributions to the Forward Fund help provide grants to promising young post-doctoral researchers, advocate for more young scientists to enter the field of cancer immunotherapy research and much more.

Learn More

Program Organizers

Justin Eyquem, PhD


Justin Eyquem, PhD
University of California - San Francisco

Chrystal Paulos, PhD Winship Cancer Institute


Chrystal Paulos, PhD
Winship Cancer Institute at Emory University

Daniel Powell, PhD


Daniel Powell Jr., PhD
University of Pennsylvania

Christian Capitini, MD

Program Advisor

Christian Capitini, MD
University of Wisconsin-Madison

Program Faculty

Kristin Anderson, PhD
University of Virginia

Panagiotis Benos, PhD
University of Florida

Peter Bruno, PhD
University of California San Francisco

Tullia Bruno, PhD
University of Pittsburgh

Deborah Collyar, BS
Patient Advocates in Research

Tricia Cottrell, MD, PhD
Queen's University

May Daher, MD
The University of Texas MD Anderson Cancer Center

Gregory Delgoffe, PhD
University of Pittsburgh

Victor Engelhard, PhD
University of Virginia School of Medicine

Olivera Finn, PhD, FAIO
University of Pittsburgh

Maryland Franklin, PhD

Elizabeth Garrett-Mayer, PhD
American Society of Clinical Oncology

Sacha Gnjatic, PhD
Ichan School of Medicine at Mount Sinai

Paola Grandi, PhD
CG Oncology

Bambi Grilley, RPh
Baylor College of Medicine

Dinesh Kumar, PhD

Lewis Lanier, PhD
University of California San Francisco

Gregory Lesinski, PhD, MPH
Winship Cancer Institute at Emory University

Gregory Lizee, PhD
The University of Texas MD Anderson Cancer Center

Michael Lotze, MD, FACS
University of Pittsburgh

Jan Joseph Melenhorst, PhD
Cleveland Clinic

Y. Maurice Morillon, PhD
U.S. Food and Drug Administration

Yana Najjar, MD
University of Pittsburgh

Paul Robbins, PhD
National Cancer Institute

Robert Scharpf, PhD
Johns Hopkins University

Melody Smith, MD, MS
Stanford University

Sumit Subudhi, MD, PhD
The University of Texas MD Anderson Cancer Center

Ryan Sullivan, MD
Harvard Medical School, Massachusetts General Hospital

Masataka Suzuki, PhD
Baylor College of Medicine

Christopher Takimoto, MD, PhD
IGM Biosciences

Ned Waller, MD, PhD
Emory University

Jianda Yuan, MD, PhD

Program Details

Continuing Education Credits

Continuing Education Credits will be available for the CIWS 2024 program. To claim Continuing Education Credits, please follow the instructions below. For more information on Continuing Education Credits for the CIWS 2024 program, please see the Learner Notification page here

How to Get Your Certificate
1. Go to http://sitc.cmecertificateonline.com/ 
2. Click on the “Winter School 2024” or “Winter School 2024 ABIM Only” link.
3. Evaluate the meeting and click the hyperlink provided on the last page to claim your credit certificate.
4. Save/Download/Print all pages of your certificate for your records.
5. If you lose your certificate, or need help, go to help.cmecertificateonline.com Questions? Email Certificate@AmedcoEmail.com

Networking Opportunities

Attendees will have opportunities to expand their professional network, developing new relationships with faculty and other thought leaders through small group breakout sessions and virtual networking features.

Target Audience

  • Early-to-mid career scientists in the field of cancer immunotherapy working in academic, clinical, industry and government settings
  • Individuals new to the field working in academic, clinical, industry and government settings

Learning Objectives

Upon completion of the Cancer Immunotherapy Winter School, participants are able to:

  • Describe the core principles of tumor immunology and cancer immunotherapy
  • Discuss recent advancements in drug and biomarker technologies and their clinical application
  • Explain appropriate clinical and/or preclinical trial data analysis methods and best practices in clinical and/or preclinical trial design

Program Statement on Diversity, Equity and Inclusion

The Society for Immunotherapy of Cancer (SITC) understands the value of diversity, equity and inclusion and is committed to closing gaps within all facets of the organization, as well as ones in the field of immuno-oncology and biomedical sciences. Since 2018, SITC has been proactively following the NIH Statement on Diversity for those in underrepresented Populations in the U.S. Biomedical Sciences across planning, solicitation and implementation of all programming, including SITC’s Cancer Immunotherapy Winter School. In 2021, SITC formed the Diversity, Equity  and Inclusion Task Force to ensure participation from nationally underrepresented racial and ethnic groups, individuals with disabilities, individuals from disadvantaged backgrounds and women from biomedical sciences throughout all society programs and initiatives.

Enduring Materials

Enduring materials are available as permitted by presenters from this past year's 2023 Cancer Immunotherapy Winter School.

Program registrants receive complimentary access to on-demand content.

Enduring materials are available for purchase for those who did not register to attend the program. A discount is available for SITC Members. Renew your dues or become a SITC member today.

View or Purchase CIWS 2023 Enduring Materials >

Related Resources

SITC offers a variety of resources about tumor immunology and cancer immunotherapy. Explore the pages below to learn more.

Basic Cancer Immunotherapy Principles

Learn the fundamentals of cancer immunotherapy through a variety of SITC programs.

Explore Resources


Discover how SITC is leveraging bioinformatics to enhance cancer immunotherapy research and treatments.

Learn More


SITC’s clinician resources includes programs on biomarkers in the field of immuno-oncology.

Read More

Clinical Data and Practical Considerations

Explore SITC's journal, the Journal for Immunotherapy of Cancer (JITC), and other clinical resources.

View More

Combination Therapies

Discover related SITC resources about Combination Therapies.

Explore Programs

Practical Application Resources

Explore SITC's resources to learn about disease specific treatment algorithms, identification and treatment of common irAEs and how to overcome challenges in the clinic.

Learn More

Professional Development

Discover related SITC resources about Professional Development.

Browse Programs